Instituto de Olhos de Goiania [clinicaltrials_resource:0de4d2ea73267eaa2fa7c2bfeb08fb70]
Larissa S Stival, MD [clinicaltrials_resource:59484eb2a97d9d94534b351df090112c]Belquiz A Nassaralla, MD PhD [clinicaltrials_resource:b65b80d5338695e70808454a51536689]Belquiz A Nassaralla, MD, PhD [clinicaltrials_resource:c2b74c3595edaf5f2d78b2d14ad91709]Adriana R Almeida, MS-V [clinicaltrials_resource:e8357adf443607f2c3e2da6e7b0d9baf]Joao J Nassaralla, PhD [clinicaltrials_resource:f31da18ec869ac4c906f7b02a7d3820f]
affiliation [clinicaltrials_vocabulary:affiliation]
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration [clinicaltrials:NCT00556348]Intraocular Bevacizumab (Avastin) for Rubeosis Iridis [clinicaltrials:NCT00557232]Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds [clinicaltrials:NCT00564213]The Effect of Bevacizumab on Corneal Neovascularization [clinicaltrials:NCT00797303]Bevacizumab Intravitreal for Myopic Choroidal Neovascularization [clinicaltrials:NCT00797992]Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old [clinicaltrials:NCT00800774]Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration [clinicaltrials:NCT01014468]Intrastromal Corneal Ring for High Astigmatism on Postkeratoplasty [clinicaltrials:NCT01018797]Ranibizumab for Myopic Neovascularization [clinicaltrials:NCT01246089]Phototherapeutic Keratectomy (PTK) on Recurrent Corneal Erosions [clinicaltrials:NCT01251692]Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin [clinicaltrials:NCT01485211]Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil [clinicaltrials:NCT01740466]Corneal Sensitivity Cross-linking Keratoconus [clinicaltrials:NCT01743443]Subconjunctival Bevacizumab and Recurrent Pterygium [clinicaltrials:NCT01744756]Different Surgical Techniques for Pterygium Surgery [clinicaltrials:NCT02002338]Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel) [clinicaltrials:NCT02008253]clinicaltrials:NCT02033018
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration [clinicaltrials:NCT00556348]Intraocular Bevacizumab (Avastin) for Rubeosis Iridis [clinicaltrials:NCT00557232]Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds [clinicaltrials:NCT00564213]The Effect of Bevacizumab on Corneal Neovascularization [clinicaltrials:NCT00797303]Bevacizumab Intravitreal for Myopic Choroidal Neovascularization [clinicaltrials:NCT00797992]Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old [clinicaltrials:NCT00800774]Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration [clinicaltrials:NCT01014468]Intrastromal Corneal Ring for High Astigmatism on Postkeratoplasty [clinicaltrials:NCT01018797]Ranibizumab for Myopic Neovascularization [clinicaltrials:NCT01246089]Phototherapeutic Keratectomy (PTK) on Recurrent Corneal Erosions [clinicaltrials:NCT01251692]Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin [clinicaltrials:NCT01485211]Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil [clinicaltrials:NCT01740466]Corneal Sensitivity Cross-linking Keratoconus [clinicaltrials:NCT01743443]Subconjunctival Bevacizumab and Recurrent Pterygium [clinicaltrials:NCT01744756]Different Surgical Techniques for Pterygium Surgery [clinicaltrials:NCT02002338]Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel) [clinicaltrials:NCT02008253]clinicaltrials:NCT02033018
source [clinicaltrials_vocabulary:source]
Instituto de Olhos de Goiania [clinicaltrials_resource:0de4d2ea73267eaa2fa7c2bfeb08fb70]
Bio2RDF identifier
0de4d2ea73267eaa2fa7c2bfeb08fb70
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0de4d2ea73267eaa2fa7c2bfeb08fb70
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:0de4d2ea73267eaa2fa7c2bfeb08fb70
title
Instituto de Olhos de Goiania
@en
type
label
Instituto de Olhos de Goiania [clinicaltrials_resource:0de4d2ea73267eaa2fa7c2bfeb08fb70]
@en